These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging. Gong J, Xu J, Zhou K, Shen K. Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113 [Abstract] [Full Text] [Related]
8. [Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings]. Gehl HB, Günther RW, Klever P, Hauptmann S. Rofo; 1993 Sep; 159(3):240-4. PubMed ID: 8397012 [Abstract] [Full Text] [Related]
10. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions. Zanello A, Nicoletti R, Brambilla P, Boccuni R, Di Carlo V, Staudacher C, Del Maschio A. Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134 [Abstract] [Full Text] [Related]
11. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver]. Vogl TJ, Hamm B, Schnell B, Eibl-Eibesfeldt B, Steiner S, Lissner J. Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599 [Abstract] [Full Text] [Related]
14. [Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent]. Steudel A, Layer G, Kraheck H, Hartlapp J, Reiser M. Rofo; 1992 May; 156(5):460-4. PubMed ID: 1596550 [Abstract] [Full Text] [Related]
15. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. Bernardino ME, Young SW, Lee JK, Weinreb JC. Radiology; 1992 Apr; 183(1):53-8. PubMed ID: 1549694 [Abstract] [Full Text] [Related]